FMP
NASDAQ
0.67 USD
0.05 (7.46%)
Mr. Gil Efron CPA, M.A.
Healthcare
Biotechnology
https://purple-biotech.com
NASDAQ
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 1b/2 clinical trials for the treatment of non-small cell lung cancer and pancreatic cancer; and NT219, a small molecule that targets insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment of recurrent and/or metastatic solid tumors and ...
0001614744
US74638P1093
74638P109
4 Oppenheimer Street
972 3 933 3121
IL
20
Nov 20, 2015
0001614744
NASDAQ
Biotechnology
Healthcare
74638P109
US74638P1093
IL
0.67
0.57
100.7k
17.38M
-
0.533-2.16
0.57
-
-
-
-
-0.74
-
https://purple-biotech.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.